Research Paper Volume 13, Issue 12 pp 16696—16712

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma

class="figure-viewer-img"

Figure 9. Survival analysis of EC patients belonging to different ICG expression subgroups. (A) Kaplan-Meier survival curves show OS of EC patients belonging to high or low IDO1 and TNFRSF14 expression groups. (B) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CD274 and TNFRSF14 expression groups. (C) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CTLA4 and TNFRSF14 expression groups. (D) Kaplan-Meier survival curves show OS of EC patients belonging to IDO1low TNFRSF14high and IDO1low TNFRSF14low expression groups. (E) Kaplan-Meier survival curves show OS of EC patients belonging to CD274low TNFRSF14high and CD274low TNFRSF14low expression groups. (F) Kaplan-Meier survival curves show OS of EC patients belonging to CTLA4low TNFRSF14high and CTLA4low TNFRSF14low expression groups. The abscissa represents survival time, and the ordinate represents overall survival.